George J Syrmalis
4 SlideShares 15 Seguidores 3 Siguiendos
Personal Information
Organización/Lugar de trabajo
Sydney, Australia Australia
Ocupación
Chairman and Group CEO at The iQ Group Global
Sector
Medical / Health Care / Pharmaceuticals
Sitio web
http://www.iqnovate.com
Acerca de
• Innovative biotechnology strategist and successful life science entrepreneur trained in Nuclear Medicine-Radiation Immunology. • Founder of the iQ Group Global, Executive Chairman of iQnovate Ltd, Executive Director of iQX Limited, and CEO of iQ3Corp. Ltd., as well as Executive Member of the iQX Investment Services, Fund Investment Committee. • Founder and former CEO and Chairman of The Bionuclear Group SA (1995-2005). The core business activities of the Group were: oncology radiopharmaceutical R&D; Operation of renal dialysis clinics for End Stage Renal Disease patients; Management and ownership of Medical Centres and reference pathology laboratories; and the development of both th...
Datos de contacto
Etiquetas
biosimilars regulatory biotechnology key opinionleaders capital investment biotech
Ver más

Presentaciones

(1)

Art And Science Of Biotech Valuations Gs Final

Hace 13 años • 2408 Visualizaciones

Documentos

(3)

KOL MANAGEMENT

Hace 12 años • 18890 Visualizaciones

Biosimilars report

Hace 12 años • 7243 Visualizaciones

Ims Perfecting Market Access In Apac

Hace 12 años • 977 Visualizaciones

Recomendaciones

(3)

Culture

Reed Hastings • Hace 14 años

Overview of FDA Regulation of Medical Devices

Michael Swit • Hace 9 años

Medical Device Regulations - 510(k) Process

Michael Haessly - SSBB, CQE, CRE, CQM, CSQE, CQA • Hace 11 años
Personal Information
Organización/Lugar de trabajo
Sydney, Australia Australia
Ocupación
Chairman and Group CEO at The iQ Group Global
Sector
Medical / Health Care / Pharmaceuticals
Sitio web
http://www.iqnovate.com
Acerca de
• Innovative biotechnology strategist and successful life science entrepreneur trained in Nuclear Medicine-Radiation Immunology. • Founder of the iQ Group Global, Executive Chairman of iQnovate Ltd, Executive Director of iQX Limited, and CEO of iQ3Corp. Ltd., as well as Executive Member of the iQX Investment Services, Fund Investment Committee. • Founder and former CEO and Chairman of The Bionuclear Group SA (1995-2005). The core business activities of the Group were: oncology radiopharmaceutical R&D; Operation of renal dialysis clinics for End Stage Renal Disease patients; Management and ownership of Medical Centres and reference pathology laboratories; and the development of both th...
Etiquetas
biosimilars regulatory biotechnology key opinionleaders capital investment biotech
Ver más